Comparison of efficacies of haploidentical transplantation and matched sibling donor transplantation in treating T‐cell lymphoblastic lymphoma
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Medicine"
DOI: 10.1002/cam4.5786
Abstract: To investigate the differences in efficacy and safety between haploidentical donor hematopoietic stem cell transplantation (HID‐HSCT) and matched sibling donor HSCT (MSD‐HSCT) in patients with T‐cell lymphoblastic lymphoma (T‐LBL). read more here.
Keywords: lymphoblastic lymphoma; matched sibling; sibling donor; cell lymphoblastic ... See more keywords
Extramedullary early T‐cell lymphoblastic crisis in a young pregnant chronic myeloid leukemia patient: Diagnosis with fine‐needle aspiration cytology and flow cytometry
Sign Up to like & getrecommendations! Published in 2022 at "Diagnostic Cytopathology"
DOI: 10.1002/dc.24947
Abstract: Chronic myeloid leukemia (CML) most commonly presents in chronic phase. Blast crisis in CML is usually of myeloid phenotype, whereas among lymphoid lineage, B‐cell lymphoblastic crisis is common. T lymphoblastic crisis is rare with near… read more here.
Keywords: chronic myeloid; crisis; lymphoblastic crisis; cell lymphoblastic ... See more keywords
Britannin mediates apoptosis and glycolysis of T-cell lymphoblastic lymphoma cells by AMPK-dependent autophagy.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of biochemical and molecular toxicology"
DOI: 10.1002/jbt.23211
Abstract: Britannin is a natural pseudoguaiacane sesquiterpene lactone, which is reported to possess a significant anticancer function. However, its anticancer effects in T-cell lymphoblastic lymphoma (T-LBL) have not been studied. We investigated the molecular mechanisms of… read more here.
Keywords: lymphoblastic lymphoma; britannin; cell lymphoblastic; lbl ... See more keywords
Durable remission of T cell lymphoblastic lymphoma relapsing after allogeneic haematopoietic stem cell transplantation with a single low dose of nivolumab
Sign Up to like & getrecommendations! Published in 2020 at "Annals of Hematology"
DOI: 10.1007/s00277-020-04042-1
Abstract: Dear Editor, A 24-year-old woman presented in 2016 with superior vena cava obstruction due to an anterior mediastinal mass (Fig. 1), confirmed pathologically to be T cell lymphoblastic lymphoma. Treatment with an acute lymphoblastic leukaemia… read more here.
Keywords: cell lymphoblastic; response; allogeneic haematopoietic; cell ... See more keywords
Clinical outcomes and prognostic factors in children with B-cell lymphoblastic lymphoma (LBL) treated according to on modified BFM-90 protocol: Experience from a Tertiary cancer care center in India.
Sign Up to like & getrecommendations! Published in 2022 at "Pediatric hematology and oncology"
DOI: 10.1080/08880018.2021.2005725
Abstract: Pediatric B-cell lymphoblastic lymphoma (LBL) is a rare entity, and appropriate treatment for pediatric B-cell LBL is not well defined. While intensive ALL type regimens achieve long term survival of 90% across Western co-operative group… read more here.
Keywords: protocol; cell lymphoblastic; bfm protocol; pediatric cell ... See more keywords
S194-P-FADD as a marker of aggressiveness and poor prognosis in human T-cell lymphoblastic lymphoma.
Sign Up to like & getrecommendations! Published in 2019 at "Carcinogenesis"
DOI: 10.1093/carcin/bgz041
Abstract: T-cell lymphoblastic lymphoma is a haematological disease with an urgent need for reliable prognostic biomarkers that allow therapeutic stratification and dose adjustment. The scarcity of human samples is responsible for the delayed progress in the… read more here.
Keywords: lymphoblastic lymphoma; s194 fadd; cell; cell lymphoblastic ... See more keywords
Precursor B-cell Lymphoblastic Lymphoma in Children: Hacettepe Experience.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of pediatric hematology/oncology"
DOI: 10.1097/mph.0000000000002656
Abstract: The purpose of the study was to review the clinical and pathologic characteristics and treatment results of children with precursor B-cell lymphoblastic lymphoma. Of 530 children diagnosed with non-Hodgkin lymphomas between 2000 and 2021, 39… read more here.
Keywords: lymphoblastic lymphoma; precursor cell; cell lymphoblastic;
FDG PET/CT Demonstrated Precursor B-cell Lymphoblastic Lymphoma in a Pediatric Patient With Hemophilia B.
Sign Up to like & getrecommendations! Published in 2019 at "Clinical Nuclear Medicine"
DOI: 10.1097/rlu.0000000000002582
Abstract: A 4-year-old boy with history of hemophilia B presented with increasingly enlarged scalp masses. Although they were initially thought as hematomas, unresponsiveness to the therapy lead to suspicion of malignancy, which prompted FDG PET/CT. The… read more here.
Keywords: fdg pet; hemophilia; pet; lymphoblastic lymphoma ... See more keywords
Detection of Chyle Leakage Site With Lymphoscintigraphy SPECT/CT in a Patient With Chylothorax Secondary to T-Cell Lymphoblastic Leukemia.
Sign Up to like & getrecommendations! Published in 2021 at "Clinical nuclear medicine"
DOI: 10.1097/rlu.0000000000003708
Abstract: ABSTRACT We present a pediatric case with T-cell lymphoblastic leukemia and persistent chylothorax who was referred to lymphoscintigraphy to identify the site of leakage. Planar lymphoscintigraphy with SPECT/CT revealed hot spots at the left jugulovenous… read more here.
Keywords: lymphoscintigraphy spect; lymphoblastic leukemia; cell lymphoblastic; lymphoscintigraphy ... See more keywords
Primary Cutaneous B‐Cell Lymphoblastic Lymphoma Arising from a Long‐Standing Lesion in a Child and Review of the Literature
Sign Up to like & getrecommendations! Published in 2017 at "Pediatric Dermatology"
DOI: 10.1111/pde.13169
Abstract: Precursor B‐cell lymphoblastic lymphoma (B‐LBL) is a rare entity and primary cutaneous B‐LBL is an even more uncommon diagnosis that typically affects children. A 4‐year‐old boy presented with a persistent rash on his left cheek… read more here.
Keywords: lymphoblastic lymphoma; primary cutaneous; cell lymphoblastic; lesion ... See more keywords
Results and conclusions of the European Intergroup EURO-LB02 trial in children and adolescents with lymphoblastic lymphoma
Sign Up to like & getrecommendations! Published in 2017 at "Haematologica"
DOI: 10.3324/haematol.2015.139162
Abstract: In the European Intergroup EURO-LB02 trial, children and adolescents with lymphoblastic lymphoma underwent the non-Hodgkin lymphoma Berlin-Frankfurt-Münster protocol without prophylactic cranial radiotherapy. The primary aims of this trial were to test whether replacing prednisone with… read more here.
Keywords: lymphoma; trial; cell lymphoblastic; european intergroup ... See more keywords